BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33269634)

  • 1. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Jan; 16(1):113-119. PubMed ID: 33269634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
    Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
    Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes.
    Yamada E; Nakajima Y; Horiguchi K; Okada S; Yamada M
    Endocr J; 2023 Dec; 70(12):1187-1193. PubMed ID: 37766568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study
    Préau Y; Galie S; Schaepelynck P; Armand M; Raccah D
    Sensors (Basel); 2021 Sep; 21(18):. PubMed ID: 34577338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
    Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
    Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
    Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
    Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
    Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
    Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
    Yoshii H; Mita T; Katakami N; Okada Y; Osonoi T; Aso K; Kurozumi A; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e3990-e4003. PubMed ID: 35908248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Frequency of Intermittently Scanned Glucose and Diurnal Variation of Glycemic Metrics.
    Hansen KW; Bibby BM
    J Diabetes Sci Technol; 2022 Nov; 16(6):1461-1465. PubMed ID: 34041961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
    Oriot P; Viry C; Vandelaer A; Grigioni S; Roy M; Philips JC; Prévost G
    J Diabetes Sci Technol; 2023 Nov; 17(6):1553-1562. PubMed ID: 35466719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impacts of glycemic variability on the relationship between time in range and estimated glycated hemoglobin in patients with type 1 diabetes mellitus].
    Peng HM; Deng HR; Zhou YW; Wang CF; Lyu J; Mai XD; Yang DZ; Lu J; Xu W; Yan JH
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1190-1195. PubMed ID: 35462500
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 Diabetes.
    Shah VN; Snell-Bergeon JK; Demmitt JK; Joshee P; Garcetti R; Pyle L; Polsky S
    Diabetes Technol Ther; 2021 Dec; 23(12):783-790. PubMed ID: 34524020
    [No Abstract]   [Full Text] [Related]  

  • 17. Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study.
    Franceschi R; Cauvin V; Stefani L; Berchielli F; Soffiati M; Maines E
    Front Endocrinol (Lausanne); 2022; 13():907517. PubMed ID: 35784525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
    Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
    Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter Randomized Trial of Intermittently Scanned Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Individuals With Type 2 Diabetes and Recent-Onset Acute Myocardial Infarction: Results of the LIBERATES Trial.
    Ajjan RA; Heller SR; Everett CC; Vargas-Palacios A; Higham R; Sharples L; Gorog DA; Rogers A; Reynolds C; Fernandez C; Rodrigues P; Sathyapalan T; Storey RF; Stocken DD
    Diabetes Care; 2023 Feb; 46(2):441-449. PubMed ID: 36516054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Zhou Y; Sardana D; Kuroko S; Haszard JJ; de Block MI; Weng J; Jefferies C; Wheeler BJ
    Diabet Med; 2024 Mar; 41(3):e15280. PubMed ID: 38197238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.